Mumbai's Haffkin?Institute gets centre's nod for production of Bharat Biotech's Covaxin

The Centre on Thursday gave permission to Mumbai's Haffkin Institute to manufacture Bharat Biotech's anti-coronavirus vaccine Covaxin.

advertisement
The Union government has given its permission to the city-based Haffkin Institute to manufacture Covaxin, an anti-coronavirus vaccine of Bharat Biotech. (File photo)

In a major development, the central government has given permission to Mumbai's Haffkin Institute to manufacture Bharat Biotech's anti-coronavirus vaccine Covaxin.

Last month, Maharashtra Chief Minister Uddhav Thackeray had demanded that Mumbai-based Haffkin Institute be allowed to produce the Covid-19 vaccines. PM Modi had responded saying all institutes in various states which can produce the vaccines will be encouraged.

Maharashtra CMO on Thursday said that CM Uddhav Thackeray has thanked Prime Minister Narendra Modi for accepting his request and allowing government to start large-scale vaccine production in Maharashtra.

The approval letter to Chief Secretary Sitaram Kunte on April 15 stated that the approval was given as per the recommendation of the committee of scientific experts and a period of one year has been given for the development of Covaxin.

The central government said that Haffkin Biopharma Corporation should start production as soon as possible in view of the current rate of growth of Covid-19 infections and demand for vaccines as well as the appointment of experienced and trained technicians.

Chief Minister Uddhav Thackeray also asked the chief secretary to appoint a senior officer to monitor the project regularly and complete the production on time.